Multaq Proclamation
Multaq : Imaging Studies
Usually the doctor will want to obtain at least one imaging study (usually a sonogram) at some point during the diagnostic evaluation of chronic hepatitis B, especially when LFTs are elevated. While an enlarged liver or spleen may be detected on occasion, in general, imaging studies are usually normal—even in advanced stages of the disease. If liver cancer (hepatoma) is present, a mass may be revealed. See chapter 19 for more information on liver tumors. However, just because the liver looks normal on an imaging study does not mean that the liver is normal. That is why a liver biopsy is necessary when more information about the condition of the liver is needed.
More information on Multaq
The Different Types of Chronic Hepatitis B
People with chronic hepatitis B may be divided into three categories: (1) inactive hepatitis B surface antigen (HBsAg) carrier state; (2) chronic hepatitis B, which is divided into HbeAg positive and HBeAg negative chronic hepatitis B; and (3) resolved chronic hepatitis B. Everyone with chronic hepatitis B is, by definition, both HBsAg and HBcAb positive. (Refer to table 9.1 on page 100 for a discussion of these and some related terms.) This means that both the hepatitis B surface antigen and core antibody are detectable in their blood.
Inactive HBsAg Corner Stote
The first type of chronic hepatitis B is found in a person who carries hepatitis B, is HBsAg and HBcAb positive, but who has normal liver enzymes (AST and ALT), a normal physical exam, and is asymptomatic. Such a person is referred to as an inactive carrier of hepatitis B. HBeAg and HBV DNA are negative, and HBeAb is typically positive—indicating that this person is not infectious to others. Inactive carriers of HBV usually have minimal, if any, liver inflammation or damage. They usually live a normal life without any complications due to their liver disease. However, compared with the genera! population, these people are at a somewhat higher risk for cirrhosis and liver cancer. Therefore, regular observation—in the form of visits to the doctor approximately one to two times per year for a physical exam and blood tests—is necessary to check for early signs of disease progression.
Information from other sources on Multaq
Liver Biopsy
As with all liver diseases, even if a person feels Fine, that’s no guarantee that her liver is fine. The only way to determine the degree to which one’s liver is injured is by examining a sample of the liver under a microscope. Therefore, in addition to obtaining a battery of blood tests, including LFTs and the hepatitis B serology, the doctor will need to perform a liver biopsy to determine the full extent of damage done to the liver by the virus and to determine if treatment is necessary. A liver
biopsy is the only reliable means of determining the presence or absence of cirrhosis. Some studies have demonstrated that the results of a liver biopsy performed promptly after diagnosis can predict the future course of disease.
Our use of the term or terms Multaq is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Multaq visit our site often.
http://www.seedol.com